Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06531473 · ClinicalTrials.gov registry record · NA
Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures
A NA study of Urologic Diseases and Prostate Obstruction, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT06531473: Recruiting NA study of Urologic Diseases and Prostate Obstruction, sponsored by Northwestern University.
NCT06531473 is a NA study of Urologic Diseases and Prostate Obstruction that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 300 participants, above the 93-participant average among 11 other Urologic Diseases trials with a reported enrollment target (223% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06531473, a NA study of Urologic Diseases and Prostate Obstruction, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim is to assess the impact of laser setting frequency and wattage during holmium laser enucleation of the prostate. There is currently no gold-standard laser settings for HoLEP procedures. In the investigator's current high-volume practice, the following settings for enucleation are: 2j 50hz. These settings are conventional settings, but there is no literature to prove optimal laser settings. The investigators hypothesizes that utilization of higher laser settings may be associated with a clinically significant (defined as \> 10%) decrease in procedural time without any detrimental postoperative outcomes, and a utilization of lower laser settings may be associated with a clinically significant (defined as \>10%) reduction in postoperative irritative voiding symptoms without any detrimental postoperative outcomes.
Primary Outcome
Comparing operative outcomes between the 40 hz, 50 hz and 60 hz laser setting groups.
Conditions Studied
Interventions
- PROCEDURE HoLEP
Study Locations (1)
Illinois
- Northwestern Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-03-04 |
| Est. Completion | 2026-08-30 |
| Phase | NA |
What NCT06531473 shows while recruiting
NCT06531473 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 93-participant average among 11 other Urologic Diseases trials with a reported enrollment target (223% higher).
The record links to 2 conditions, with Urologic Diseases appearing as the primary indexed condition, and to 1 intervention - of which HoLEP is the first listed.
NCT06531473 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06531473 about?
NCT06531473 is a clinical study titled "Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures". The primary aim is to assess the impact of laser setting frequency and wattage during holmium laser enucleation of the prostate. There is currently no gold-standard laser settings for HoLEP procedures. In the investigator's current high-volume practice, the following settings for enucleation are: 2j...
What is the current status of trial NCT06531473?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-03-04. Estimated completion is 2026-08-30.
What conditions does trial NCT06531473 study?
This clinical trial studies the following conditions: Urologic Diseases, Prostate Obstruction.
What interventions are being tested in trial NCT06531473?
The interventions under investigation include: HoLEP (PROCEDURE).
Who is sponsoring clinical trial NCT06531473?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06531473 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urologic Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06531473's enrollment target sits among peer trials
300 2nd of 11 the highest of 11 other Urologic Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urologic Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Satisfaction of Virtual vs In-Person Workup and Treatment of Lower Urinary Tract Symptoms.
RECRUITING · NA
-
Trial for Reliability of Urodynamics SysTem
RECRUITING · NA
-
INTIBIA Pivotal Study
ACTIVE NOT RECRUITING · NA
-
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
COMPLETED · NA
-
Percutaneous Externally-Assembled Laparoscopic Urologic Surgery
COMPLETED · NA
-
Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI